Therapeutic Control of Aspirin-Exacerbated Respiratory Disease.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 10 Jan 2017
At a glance
- Drugs Prasugrel (Primary) ; Aspirin
- Indications Asthma
- Focus Adverse reactions; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 04 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 25 Apr 2016 Planned End Date changed from 1 Jan 2016 to 1 Mar 2017.